Alpa Laboratories Limited — Investor Relations & Filings
Alpa Laboratories Limited specializes in the development and manufacture of a broad range of pharmaceutical formulations for human and veterinary applications. The company's core capabilities include the production of small volume parenterals, such as liquid and dry powder injections, alongside solid orals like tablets and capsules. Its portfolio further extends to topical preparations including ointments, creams, gels, and ophthalmic/otic drops. Utilizing WHO-GMP certified manufacturing units, the organization provides extensive contract manufacturing and research services to prominent global healthcare brands. The company serves diverse therapeutic segments, including anti-infectives, analgesics, and nutritional supplements, maintaining a robust presence in both domestic and international markets through a commitment to stringent quality standards and technical excellence.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Financial Result Updates | 2023-11-07 | English | |
| Board Meeting — ALPA LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for… | 2023-11-01 | English | |
| Board Meeting — Financial Results | 2023-10-26 | English | |
| Trading Window | 2023-10-03 | English | |
| Shareholders meeting | 2023-09-30 | English | |
| Shareholders meeting | 2023-09-29 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 42791982 | Financial Result Updates | 2023-11-07 | English | ||
| 43991310 | Board Meeting — ALPA LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for… | 2023-11-01 | English | ||
| 43991324 | Board Meeting — Financial Results | 2023-10-26 | English | ||
| 42741767 | Trading Window | 2023-10-03 | English | ||
| 42754266 | Shareholders meeting | 2023-09-30 | English | ||
| 42778310 | Shareholders meeting | 2023-09-29 | English | ||
| 42739867 | Book Closure | 2023-09-12 | English | ||
| 42753138 | Updates | 2023-09-11 | English | ||
| 42770670 | Updates | 2023-08-28 | English | ||
| 42770703 | Outcome of Board Meeting | 2023-08-28 | English | ||
| 42772053 | Updates | 2023-08-21 | English | ||
| 42773415 | Appointment | 2023-08-16 | English | ||
| 42800074 | Financial Result Updates | 2023-08-14 | English | ||
| 43980318 | Board Meeting — Financial Results | 2023-08-02 | English | ||
| 42815247 | Disclosure under SEBI Takeover Regulations | 2023-07-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Alpa Laboratories Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61196/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61196 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61196 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61196 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61196}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alpa Laboratories Limited (id: 61196)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.